The Board has decided to remand the case for an addendum opinion regarding the Veteran's development of Congestive Heart Failure (CHF)/Heart Disease due to the prescribing of Rosiglitazone in October 2002.
The deciding factor: The September 2013 VA examiner did not address the drug information warning about fluid retention and its potential link to CHF, nor did he comment on whether the Veteran exhibited fluid retention or had a family history of heart disease.
- Claimed conditions
- Bilateral Eye Condition, Kidney Failure, Anemia, Gastrointestinal Damage/GERD, Congestive Heart Failure (CHF)/Heart Disease
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- September 21, 2018
- Citation
- 18137594
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 18137594.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Veteran's claim of service connection for GERD has been readjudicated due to the submission of relevant new evidence.,The Veteran's claims of service connection for bilateral eye condition, headaches, low back condition, lung cancer, and Parkinson's disease with tremors have also been readjudicated due to the submission of relevant new evidence.
- Granted
The Veteran's right knee disability (status post total knee arthroplasty) is rated at 60 percent prior to December 10, 2024 and denied for higher ratings thereafter. His left knee disability remains at 10 percent. The bilateral eye condition was initially rated at 10 percent but increased to 20 percent beginning December 12, 2024. TDIU is granted prior to August 1, 2023.
- Remanded (sent back)
The Board has remanded the Veteran's claims for service connection for various conditions due to a lack of VA examinations and consideration of all relevant evidence, including his National Guard service.
- Granted
The Veteran's hemorrhoids were rated at 20 percent from June 13, 2011. The Board found that the evidence demonstrated persistent bleeding and anemia secondary to the hemorrhoids throughout this period.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.